Nanobodies: new avenue to treat kidney disease
Beteiligte Einrichtungen
Abstract
Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| ISSN | 0302-766X |
| DOIs | |
| Status | Veröffentlicht - 08.2021 |
| PubMed | 34131806 |
|---|
